MPG.eBooks - Search Results - "finality"

Search alternatives:
"finality" » "finally", "finalize"

Cover Image

1

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

2

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

3

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

4

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

5

CADTH CDEC final recommendation: Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

8

CDEC final recommendation: Tiotropium bromide (Spiriva respimat -- Boehringer Ingelheim Canada Ltd.) : indication : chronic obstructive pulmonary disease

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

9

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

10

CADTH Canadian Drug Expert Committee final recommendation: Mifepristone and misoprostol (Mifegymiso...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

11

CADTH Canadian Drug Expert Committee final recommendation: Mifepristone and misoprostol (Mifegymiso...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

12

CADTH Canadian Drug Expert Review Committee final recommendation: Adalimumab (Humira -- abbVie) : indication: ulcerative colitis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

13

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee final...”

Cover Image

14

CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

15

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

16

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee final...”

Cover Image

17

CADTH Canadian Drug Expert Committee final recommendation: Selexipag (Uptravi -- Actelion...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

18

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee final...”

Cover Image

19

CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

20

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee final...”

1
2
3
4
5
6
7
8
9
10
11